Form 4 for OABI OmniAb, Inc.
Accepted 2022-11-03 00:00:00 ET · period of report 2022-11-01 · accession 0000899243-22-035050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-03 | 2022-11-01 | OABI | FOEHR MATTHEW W | Pres, CEO, Dir | A - Grant | — | +1.31M | 1.31M | New | — |
| DM | 2022-11-03 | 2022-11-01 | OABI | FOEHR MATTHEW W | Pres, CEO, Dir | A - Grant | — | +1.39M | 270.6K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-01 | A | A | 1,305,350 | — | 1,305,350 | D | — | — | (F3) Includes 264,760 earn-out shares subject to forfeiture provisions described in the Merger Agreement. (F2) Includes 176,076 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and does not expire. (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. |
| 2 | Derivative | Stock Option | 2022-11-01 | A | A | 56,233 | — | 56,233 | D | $20.36 · — to 2031-02-03 | 56,233 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F7) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 3, 2021, and in 42 substantially equal monthly installments thereafter. |
| 3 | Derivative | Stock Option | 2022-11-01 | A | A | 298,311 | — | 298,311 | D | $10.41 · — to 2032-05-05 | 298,311 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F8) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 5, 2022, and in 42 substantially equal monthly installments thereafter. |
| 4 | Derivative | Stock Option | 2022-11-01 | A | A | 142,168 | — | 142,168 | D | $10.98 · — to 2030-02-13 | 142,168 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F6) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 13, 2020, and in 42 substantially equal monthly installments thereafter. |
| 5 | Derivative | Stock Option | 2022-11-01 | A | A | 146,325 | — | 146,325 | D | $13.54 · — to 2029-02-11 | 146,325 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F5) The stock option vests and is exercisable as to 12.5% of the underlying shares on August 11, 2019, and in 42 substantially equal monthly installments thereafter. |
| 6 | Derivative | Stock Option | 2022-11-01 | A | A | 86,790 | — | 86,790 | D | $18.24 · — to 2028-03-02 | 86,790 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 7 | Derivative | Stock Option | 2022-11-01 | A | A | 104,231 | — | 104,231 | D | $11.52 · — to 2027-02-24 | 104,231 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 8 | Derivative | Stock Option | 2022-11-01 | A | A | 111,038 | — | 111,038 | D | $9.84 · — to 2026-02-11 | 111,038 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 9 | Derivative | Stock Option | 2022-11-01 | A | A | 172,768 | — | 172,768 | D | $6.46 · — to 2025-02-10 | 172,768 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |
| 10 | Derivative | Stock Option | 2022-11-01 | A | A | 270,595 | — | 270,595 | D | $8.54 · — to 2024-02-12 | 270,595 Common Stock | (F1) Pursuant to the business combination of Avista Public Acquisition Corp. II and OmniAb, Inc. ("Legacy OmniAb"), as contemplated by an agreement and plan of merger, dated March 23, 2022 (the "Merger Agreement"), each share of common stock, option and award of restricted stock unit of Legacy OmniAb automatically converted into the right to receive securities of the Issuer with the same terms and conditions in accordance with an exchange ratio described in the Merger Agreement. (F4) The stock option is fully vested and exercisable. |